CD8A and neoplasm: In addition, we found that the strong reduction in tumor growth by anti‐PD‐1 treatment in control (Drp1fl/fl) mice correlates with a rescue of Drp1 phosphorylation in PD‐1pos CD8+ T cells to a level comparable to PD‐1neg CD8+ T cells (Fig. 4D).